Measuring the construct of executive control in schizophrenia: Defining and validating translational animal paradigms for discovery research

Gary Gilmour, Alexander Arguello, Andrea Bari, Verity J. Brown, Cameron S Carter, Stan B. Floresco, David J. Jentsch, David S. Tait, Jared W. Young, Trevor W. Robbins

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Executive control is an aspect of cognitive function known to be impaired in schizophrenia. Previous meetings of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) group have more precisely defined executive control in terms of two constructs: "rule generation and selection", and "dynamic adjustments of control". Next, human cognitive tasks that may effectively measure performance with regard to these constructs were identified to be developed into practical and reliable measures for use in treatment development. The aim of this round of CNTRICS meetings was to define animal paradigms that have sufficient promise to warrant further investigation for their utility in measuring these constructs. Accordingly, "reversal learning" and the "attentional set-shifting task" were nominated to assess the construct of rule generation and selection, and the "stop signal task" for the construct of dynamic adjustments of control. These tasks are described in more detail here, with a particular focus on their utility for drug discovery efforts. Presently, each assay has strengths and weaknesses with regard to this point and increased emphasis on improving practical aspects of testing, understanding predictive validity, and defining biomarkers of performance represent important objectives in attaining confidence in translational validity here.

Original languageEnglish (US)
Pages (from-to)2125-2140
Number of pages16
JournalNeuroscience and Biobehavioral Reviews
Volume37
Issue number9
DOIs
StatePublished - Nov 2013

Fingerprint

Executive Function
Cognition
Social Adjustment
Schizophrenia
Research
Reversal Learning
Drug Discovery
Biomarkers
Cognitive Neuroscience

Keywords

  • Cognition
  • Cognitive neuroscience
  • Drug discovery
  • Executive control
  • Reversal
  • Schizophrenia
  • Set-shifting
  • Stop signal

ASJC Scopus subject areas

  • Behavioral Neuroscience
  • Cognitive Neuroscience
  • Neuropsychology and Physiological Psychology

Cite this

Measuring the construct of executive control in schizophrenia : Defining and validating translational animal paradigms for discovery research. / Gilmour, Gary; Arguello, Alexander; Bari, Andrea; Brown, Verity J.; Carter, Cameron S; Floresco, Stan B.; Jentsch, David J.; Tait, David S.; Young, Jared W.; Robbins, Trevor W.

In: Neuroscience and Biobehavioral Reviews, Vol. 37, No. 9, 11.2013, p. 2125-2140.

Research output: Contribution to journalArticle

Gilmour, Gary ; Arguello, Alexander ; Bari, Andrea ; Brown, Verity J. ; Carter, Cameron S ; Floresco, Stan B. ; Jentsch, David J. ; Tait, David S. ; Young, Jared W. ; Robbins, Trevor W. / Measuring the construct of executive control in schizophrenia : Defining and validating translational animal paradigms for discovery research. In: Neuroscience and Biobehavioral Reviews. 2013 ; Vol. 37, No. 9. pp. 2125-2140.
@article{38d5daa329cd456083f6b6d0d334f5eb,
title = "Measuring the construct of executive control in schizophrenia: Defining and validating translational animal paradigms for discovery research",
abstract = "Executive control is an aspect of cognitive function known to be impaired in schizophrenia. Previous meetings of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) group have more precisely defined executive control in terms of two constructs: {"}rule generation and selection{"}, and {"}dynamic adjustments of control{"}. Next, human cognitive tasks that may effectively measure performance with regard to these constructs were identified to be developed into practical and reliable measures for use in treatment development. The aim of this round of CNTRICS meetings was to define animal paradigms that have sufficient promise to warrant further investigation for their utility in measuring these constructs. Accordingly, {"}reversal learning{"} and the {"}attentional set-shifting task{"} were nominated to assess the construct of rule generation and selection, and the {"}stop signal task{"} for the construct of dynamic adjustments of control. These tasks are described in more detail here, with a particular focus on their utility for drug discovery efforts. Presently, each assay has strengths and weaknesses with regard to this point and increased emphasis on improving practical aspects of testing, understanding predictive validity, and defining biomarkers of performance represent important objectives in attaining confidence in translational validity here.",
keywords = "Cognition, Cognitive neuroscience, Drug discovery, Executive control, Reversal, Schizophrenia, Set-shifting, Stop signal",
author = "Gary Gilmour and Alexander Arguello and Andrea Bari and Brown, {Verity J.} and Carter, {Cameron S} and Floresco, {Stan B.} and Jentsch, {David J.} and Tait, {David S.} and Young, {Jared W.} and Robbins, {Trevor W.}",
year = "2013",
month = "11",
doi = "10.1016/j.neubiorev.2012.04.006",
language = "English (US)",
volume = "37",
pages = "2125--2140",
journal = "Neuroscience and Biobehavioral Reviews",
issn = "0149-7634",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Measuring the construct of executive control in schizophrenia

T2 - Defining and validating translational animal paradigms for discovery research

AU - Gilmour, Gary

AU - Arguello, Alexander

AU - Bari, Andrea

AU - Brown, Verity J.

AU - Carter, Cameron S

AU - Floresco, Stan B.

AU - Jentsch, David J.

AU - Tait, David S.

AU - Young, Jared W.

AU - Robbins, Trevor W.

PY - 2013/11

Y1 - 2013/11

N2 - Executive control is an aspect of cognitive function known to be impaired in schizophrenia. Previous meetings of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) group have more precisely defined executive control in terms of two constructs: "rule generation and selection", and "dynamic adjustments of control". Next, human cognitive tasks that may effectively measure performance with regard to these constructs were identified to be developed into practical and reliable measures for use in treatment development. The aim of this round of CNTRICS meetings was to define animal paradigms that have sufficient promise to warrant further investigation for their utility in measuring these constructs. Accordingly, "reversal learning" and the "attentional set-shifting task" were nominated to assess the construct of rule generation and selection, and the "stop signal task" for the construct of dynamic adjustments of control. These tasks are described in more detail here, with a particular focus on their utility for drug discovery efforts. Presently, each assay has strengths and weaknesses with regard to this point and increased emphasis on improving practical aspects of testing, understanding predictive validity, and defining biomarkers of performance represent important objectives in attaining confidence in translational validity here.

AB - Executive control is an aspect of cognitive function known to be impaired in schizophrenia. Previous meetings of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) group have more precisely defined executive control in terms of two constructs: "rule generation and selection", and "dynamic adjustments of control". Next, human cognitive tasks that may effectively measure performance with regard to these constructs were identified to be developed into practical and reliable measures for use in treatment development. The aim of this round of CNTRICS meetings was to define animal paradigms that have sufficient promise to warrant further investigation for their utility in measuring these constructs. Accordingly, "reversal learning" and the "attentional set-shifting task" were nominated to assess the construct of rule generation and selection, and the "stop signal task" for the construct of dynamic adjustments of control. These tasks are described in more detail here, with a particular focus on their utility for drug discovery efforts. Presently, each assay has strengths and weaknesses with regard to this point and increased emphasis on improving practical aspects of testing, understanding predictive validity, and defining biomarkers of performance represent important objectives in attaining confidence in translational validity here.

KW - Cognition

KW - Cognitive neuroscience

KW - Drug discovery

KW - Executive control

KW - Reversal

KW - Schizophrenia

KW - Set-shifting

KW - Stop signal

UR - http://www.scopus.com/inward/record.url?scp=84888845466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888845466&partnerID=8YFLogxK

U2 - 10.1016/j.neubiorev.2012.04.006

DO - 10.1016/j.neubiorev.2012.04.006

M3 - Article

C2 - 22548905

AN - SCOPUS:84888845466

VL - 37

SP - 2125

EP - 2140

JO - Neuroscience and Biobehavioral Reviews

JF - Neuroscience and Biobehavioral Reviews

SN - 0149-7634

IS - 9

ER -